BR112021026790A2 - Composto de pirimidina-5-carboxamida - Google Patents
Composto de pirimidina-5-carboxamidaInfo
- Publication number
- BR112021026790A2 BR112021026790A2 BR112021026790A BR112021026790A BR112021026790A2 BR 112021026790 A2 BR112021026790 A2 BR 112021026790A2 BR 112021026790 A BR112021026790 A BR 112021026790A BR 112021026790 A BR112021026790 A BR 112021026790A BR 112021026790 A2 BR112021026790 A2 BR 112021026790A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyrimidine
- carboxamide compound
- compound
- carboxamide
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
composto de pirimidina-5-carboxamida. a presente invenção refere-se a um composto da fórmula ou um sal farmaceuticamente aceitável do mesmo, e métodos para usar este composto para tratar diabetes mellitus do tipo 2.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382686 | 2019-08-06 | ||
| EP19382744 | 2019-09-02 | ||
| PCT/US2020/044394 WO2021025975A1 (en) | 2019-08-06 | 2020-07-31 | Pyrimidine-5-carboxamide compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021026790A2 true BR112021026790A2 (pt) | 2022-05-10 |
Family
ID=71950845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021026790A BR112021026790A2 (pt) | 2019-08-06 | 2020-07-31 | Composto de pirimidina-5-carboxamida |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220274933A1 (pt) |
| EP (1) | EP4010324B1 (pt) |
| JP (1) | JP7261349B2 (pt) |
| KR (1) | KR20220046564A (pt) |
| CN (1) | CN114364659A (pt) |
| AU (1) | AU2020326552B2 (pt) |
| BR (1) | BR112021026790A2 (pt) |
| CA (1) | CA3145694A1 (pt) |
| ES (1) | ES2963560T3 (pt) |
| IL (1) | IL290345A (pt) |
| MX (1) | MX2022001413A (pt) |
| WO (1) | WO2021025975A1 (pt) |
| ZA (1) | ZA202200234B (pt) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20240097T1 (hr) * | 2011-04-22 | 2024-03-29 | Signal Pharmaceuticals, Llc | Supstituirani diaminokarboksamid i diaminokarbonitril pirimidini, njihovi pripravci i postupci liječenja s njima |
| CA2856306A1 (en) * | 2011-11-23 | 2013-05-30 | Portola Pharmaceuticals, Inc. | Selective kinase inhibitors |
| US11401243B2 (en) | 2017-03-30 | 2022-08-02 | The Board Of Regents Of The University Of Texas System | Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereof |
| WO2021163683A1 (en) * | 2020-02-14 | 2021-08-19 | President And Fellows Of Harvard College | Inhibitors of nicotinamide n-methyltransferase, compositions and uses thereof |
-
2020
- 2020-07-31 MX MX2022001413A patent/MX2022001413A/es unknown
- 2020-07-31 BR BR112021026790A patent/BR112021026790A2/pt unknown
- 2020-07-31 CA CA3145694A patent/CA3145694A1/en active Pending
- 2020-07-31 EP EP20751840.8A patent/EP4010324B1/en active Active
- 2020-07-31 CN CN202080056028.0A patent/CN114364659A/zh active Pending
- 2020-07-31 ES ES20751840T patent/ES2963560T3/es active Active
- 2020-07-31 JP JP2022506924A patent/JP7261349B2/ja active Active
- 2020-07-31 US US17/631,672 patent/US20220274933A1/en active Pending
- 2020-07-31 WO PCT/US2020/044394 patent/WO2021025975A1/en unknown
- 2020-07-31 KR KR1020227003910A patent/KR20220046564A/ko not_active Application Discontinuation
- 2020-07-31 AU AU2020326552A patent/AU2020326552B2/en active Active
-
2022
- 2022-01-04 ZA ZA2022/00234A patent/ZA202200234B/en unknown
- 2022-02-03 IL IL290345A patent/IL290345A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20220274933A1 (en) | 2022-09-01 |
| CN114364659A (zh) | 2022-04-15 |
| IL290345A (en) | 2022-04-01 |
| AU2020326552A8 (en) | 2022-03-31 |
| JP2022543265A (ja) | 2022-10-11 |
| EP4010324A1 (en) | 2022-06-15 |
| WO2021025975A1 (en) | 2021-02-11 |
| AU2020326552A1 (en) | 2022-02-24 |
| JP7261349B2 (ja) | 2023-04-19 |
| KR20220046564A (ko) | 2022-04-14 |
| MX2022001413A (es) | 2022-03-29 |
| ES2963560T3 (es) | 2024-03-27 |
| CA3145694A1 (en) | 2021-02-11 |
| AU2020326552B2 (en) | 2023-05-11 |
| ZA202200234B (en) | 2023-07-26 |
| EP4010324B1 (en) | 2023-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021023923A2 (pt) | Agonistas de receptor de peptídeo 1 similares a glucagon | |
| DOP2020000037A (es) | Derivados de 3-(1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos | |
| ECSP20069418A (es) | Compuestos heterocíclicos como inmunomoduladores | |
| DOP2019000187A (es) | Compuestos de 5-metil-1,2,4-oxadiazol-3-ilo | |
| CL2018000198A1 (es) | Composiciones de arni de transtiretina (ttr) y métodos para su uso para el tratamiento o prevencion de enfermedades asociadas con ttr | |
| EA202092490A1 (ru) | Модуляторы метилмодифицирующих ферментов, композиции и их применения | |
| CL2019003126A1 (es) | Métodos de tratamiento mediante el uso de un compuesto inhibidor de jak. | |
| MX2020004534A (es) | Moduladores de la vía integrada del estrés. | |
| CO2020014586A2 (es) | Compuestos | |
| BR112014003237A2 (pt) | compostos de indazol, composições e métodos de uso | |
| EA202191991A1 (ru) | Новые производные гетеротрициклического соединения и их применение | |
| BR112017002403A2 (pt) | formas de cristais de inibidores de glutaminase | |
| MY194468A (en) | Oxy-fluoropiperidine derivatives as kinase inhhiitor | |
| CL2019001041A1 (es) | Compuestos terapéuticos y métodos para utilizarlos. | |
| BRPI0820668A2 (pt) | Derivados de oxindol substituídos por 5-halogênio e seu uso para tratar doenças dependentes de vasopressina | |
| BR112019007576A2 (pt) | compostos de bifenil sulfonamida para o tratamento de doenças ou transtornos renais | |
| PE20211595A1 (es) | Compuestos de 2,6-diaminopiridina | |
| WO2016068580A3 (en) | Novel pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (kdms) | |
| MX2020013297A (es) | Compuestos para el tratamiento o la prevencion de enfermedades hepaticas. | |
| BR112021018578A2 (pt) | Compostos de heterociclil(fenil)metanol úteis no tratamento de hiperglicemia | |
| UY33568A (es) | Compuestos que interactuan con proteina reguladora de glucocinasa para el tratamiento de diabetes. | |
| BR112023025789A2 (pt) | Nitroxolina para uso no tratamento de neurofibroma cutâneo | |
| BR112017021583A2 (pt) | métodos para o tratamento de transtornos inflamatórios | |
| CO2019013254A2 (es) | Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias | |
| MX2020004842A (es) | Compuestos heterociclicos antiinfecciosos y sus usos. |